24th International Papillomavirus Conference and Clinical Workshop

Conference details
Saturday 3 November 2007 - Saturday 10 November 2007
Event type: 
Beijing, China

This conference is the second meeting of its kind to be held in Asia since Kyoto in 1984. Researchers working on all aspects of papillomaviruses and related infections and cancers are welcome to participate. The recent approval by the US FDA of an HPV vaccine to prevent high-risk HPV infection and development of cervical cancer represents a major landmark to eliminate the suffering and death due to cancer. The Beijing Conference will highlight this milestone achievement and will provide a unique forum for scientists from all the specialized fields to discuss and exchange their scientific data and ideas on various current research topics.